Related Experiment Video
Updated: Apr 23, 2026
11:50
Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
Published on: June 8, 2022
4.4K
Lipodystrophy look-alikes: navigating diagnostic overlap with endocrine diseases
Giovanni Ceccarini1, Donatella Gilio1, Silvia Magno1
1Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa 56100, Italy.
European Journal of Endocrinology
|April 21, 2026
Summary
Lipodystrophy syndromes, rare disorders of adipose tissue absence, are often misdiagnosed due to overlapping symptoms with common endocrine diseases. Early recognition and accurate diagnosis are vital for effective management and preventing severe metabolic complications.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Rare Diseases
Background:
- Lipodystrophy syndromes are rare, heterogeneous disorders marked by adipose tissue absence, leading to severe metabolic complications like insulin resistance and diabetes.
- Their rarity and variability cause underrecognition and misdiagnosis as common endocrine disorders, delaying crucial treatment.
Purpose of the Study:
- To address diagnostic challenges in lipodystrophy by distinguishing it from other endocrine conditions.
- To provide practical guidance on clinical, biochemical, and imaging features for accurate lipodystrophy diagnosis.
Main Methods:
- Review of clinical, biochemical, and imaging features of lipodystrophy.
- Analysis of overlapping manifestations with common endocrine diseases.
- Integration of structured diagnostic approaches, including decision-tree and photography-based tools.
Main Results:
- Lipodystrophy shares clinical features with endocrine diseases, posing diagnostic difficulties.
- Key differentiating features across clinical, biochemical, and imaging modalities were identified.
- Structured diagnostic tools can aid in timely identification.
Conclusions:
- Accurate and early diagnosis of lipodystrophy is crucial for preventing severe metabolic complications.
- Distinguishing lipodystrophy from endocrine "look-alikes" requires careful assessment of specific features.
- This review offers a framework to improve diagnostic accuracy and patient outcomes.
More Related Videos
Related Concept Videos
01:24Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K
01:19Cushing Syndrome II: Pathophysiology
7
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
7
01:19Type I Diabetes III: Clinical Manifestations
12
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
12
01:24Type II Diabetes II: Pathophysiology
6
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
01:23Hypothyroidism II: Pathophysiology
11
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
11
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
5
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
5